59 related articles for article (PubMed ID: 25801818)
1. FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.
Dahan R; Sega E; Engelhardt J; Selby M; Korman AJ; Ravetch JV
Cancer Cell; 2015 Sep; 28(3):285-95. PubMed ID: 26373277
[TBL] [Abstract][Full Text] [Related]
2. Combination cancer immunotherapy and new immunomodulatory targets.
Mahoney KM; Rennert PD; Freeman GJ
Nat Rev Drug Discov; 2015 Aug; 14(8):561-84. PubMed ID: 26228759
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer.
Hashemi-Sadraei N; Sikora AG; Brizel DM
Am Soc Clin Oncol Educ Book; 2016; 35():e277-82. PubMed ID: 27249733
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy-Summary of Advances and Future Directions for Studying These Drugs.
Loo K; Daud AI
Cancer J; 2017; 23(1):3-9. PubMed ID: 28114249
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy: Combined immunoradiotherapy reinvigorates antitumour immunity.
Killock D
Nat Rev Clin Oncol; 2015 Jun; 12(6):311. PubMed ID: 25801818
[No Abstract] [Full Text] [Related]
6. Immunotherapy: A triple blow for cancer.
Leavy O
Nat Rev Cancer; 2015 May; 15(5):258-9. PubMed ID: 25833214
[No Abstract] [Full Text] [Related]
7. Tumour immunology: A triple blow for cancer.
Leavy O
Nat Rev Immunol; 2015 May; 15(5):265. PubMed ID: 25814401
[No Abstract] [Full Text] [Related]
8. PD-L1 Upregulation Drives Escape from Anti-CTLA4 and Radiation Therapy.
Cancer Discov; 2015 May; 5(5):OF13. PubMed ID: 25790979
[No Abstract] [Full Text] [Related]
9. Radiotherapy and immune checkpoint blockade: potential interactions and future directions.
Binder DC; Fu YX; Weichselbaum RR
Trends Mol Med; 2015 Aug; 21(8):463-5. PubMed ID: 26091823
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy complements immune checkpoint blockade.
Ngiow SF; McArthur GA; Smyth MJ
Cancer Cell; 2015 Apr; 27(4):437-8. PubMed ID: 25873170
[TBL] [Abstract][Full Text] [Related]
11. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
Twyman-Saint Victor C; Rech AJ; Maity A; Rengan R; Pauken KE; Stelekati E; Benci JL; Xu B; Dada H; Odorizzi PM; Herati RS; Mansfield KD; Patsch D; Amaravadi RK; Schuchter LM; Ishwaran H; Mick R; Pryma DA; Xu X; Feldman MD; Gangadhar TC; Hahn SM; Wherry EJ; Vonderheide RH; Minn AJ
Nature; 2015 Apr; 520(7547):373-7. PubMed ID: 25754329
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
